| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | GSK 269962 |
|---|
| Description | Potent Rho kinase (ROCK) inhibitor (IC50 values are 1.6 and 4 nM for recombinant human ROCK1 and ROCK2 respectively). Displays greater than 30-fold selectivity for ROCK against a panel of serine/threonine kinases. Induces vasorelaxation in preconstricted rat aorta (IC50 = 35 nM); lowers blood pressure in a rat model of hypertension. Purity 99%. MW (observed): 570.6 |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N-[3-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[2-(4-morpholinyl)ethoxy]benzamide |
|---|
| Gene, Accession, CAS # | CAS: 850664-21-0 |
|---|
| Catalog # | 4009/50 |
|---|
| Price | |
|---|
| Order / More Info | GSK 269962 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 24076962, 25261469, 25264362, 27036020, 27820945 |
|---|
| 產(chǎn)品資料 |
|
|